ClinicalTrials.gov
ClinicalTrials.gov Menu

Bee Venom Acupuncture for the Treatment of Chronic Low Back Pain

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01491321
Recruitment Status : Unknown
Verified March 2012 by JLee, Kyunghee University Medical Center.
Recruitment status was:  Recruiting
First Posted : December 14, 2011
Last Update Posted : March 21, 2012
Sponsor:
Collaborator:
Kyung Hee University Hospital at Gangdong
Information provided by (Responsible Party):
JLee, Kyunghee University Medical Center

Brief Summary:
The purpose of this study is to evaluate the efficacy of bee venom acupuncture on pain intensity, functional status and quality of life of patients with chronic low back pain.

Condition or disease Intervention/treatment Phase
Chronic Low Back Pain Procedure: Bee Venom Acupuncture Therapy Drug: Loxoprofen Procedure: Placebo Phase 2

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 54 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Clinical Trial to Evaluate the Efficacy of Bee Venom Acupuncture on Chronic Low Back Pain
Study Start Date : April 2011
Estimated Primary Completion Date : March 2012
Estimated Study Completion Date : March 2012

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Bee Venom Acupuncture & Loxoprofen Procedure: Bee Venom Acupuncture Therapy

Bee Venom 1:20,000 under BVA Increment Protocol

Increment Protocol as

  • 1st week : SC 0.2cc/day, 2days/week
  • 2nd week : SC 0.4cc/day, 2days/week
  • 3rd week : SC 0.8cc/day, 2days/week
Other Name: pharmacopuncture

Drug: Loxoprofen
60 mg/Tab, pers os 1Tab tid, for 3 weeks
Other Name: Loxonin

Placebo Comparator: Sham Bee Venom Acupuncture & Loxoprofen Drug: Loxoprofen
60 mg/Tab, pers os 1Tab tid, for 3 weeks
Other Name: Loxonin

Procedure: Placebo

Normal Saline (0.9% NaCl) under NS Increment Protocol

Increment Protocol as

  • 1st week : SC 0.2cc/day, 2days/week
  • 2nd week : SC 0.4cc/day, 2days/week
  • 3rd week : SC 0.8cc/day, 2days/week




Primary Outcome Measures :
  1. Visual Analogue Scale for bothersomeness [ Time Frame: Changes from baseline in VAS at 1 month ]

Secondary Outcome Measures :
  1. Visual Analogue Scale for pain intensity [ Time Frame: Changes from baseline in VAS at 1 month ]
  2. Disability scores on Oswestry Disability Index [ Time Frame: Changes from baseline in ODI at 1 month ]
  3. Quality of Life scores on EQ-5D [ Time Frame: Changes from baseline in EQ-5D at 1 month ]
  4. Depression scores on Beck Depression Inventory [ Time Frame: Changes from baseline in BDI at 1 month ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • nonspecific, chronic low back pain over 3 months
  • Must have LBP of more than VAS 4

Exclusion Criteria:

  • cancer, vertebral fracture, spinal infection, inflammatory spondylitis
  • spinal operation
  • radicular pain
  • other musculoskeletal pain
  • physicological or mental disorders
  • allergic history to BV therapy or insect bite

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01491321


Contacts
Contact: Byung-Kwan Seo 82-2-440-7482 seohbk@hanmail.net

Locations
Korea, Republic of
Spine Center, Kyung Hee University Hospital at Gangdong Recruiting
Seoul, Korea, Republic of, 134-727
Contact: Byung-Kwan Seo       seohbk@hanmail.net   
Contact: Yoon-Su Park    82-2-440-7482      
Sponsors and Collaborators
Kyunghee University Medical Center
Kyung Hee University Hospital at Gangdong
Investigators
Principal Investigator: Jun-Hwan Lee Spine Center, Kyung Hee University Hospital at Gangdong
Study Director: Byung-Kwan Seo Spine Center, Kyung Hee University Hospital at Gangdong
Study Director: Dae-Jin Cho Spine Center, Kyung Hee University Hospital at Gangdong

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: JLee, Clinical Assistant Professor, Kyunghee University Medical Center
ClinicalTrials.gov Identifier: NCT01491321     History of Changes
Other Study ID Numbers: KHNMC-OH-IRB 2011-006
First Posted: December 14, 2011    Key Record Dates
Last Update Posted: March 21, 2012
Last Verified: March 2012

Keywords provided by JLee, Kyunghee University Medical Center:
chronic low back pain
bee venom acupuncture

Additional relevant MeSH terms:
Back Pain
Low Back Pain
Pain
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Loxoprofen
Anti-Inflammatory Agents, Non-Steroidal
Analgesics, Non-Narcotic
Analgesics
Sensory System Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Anti-Inflammatory Agents
Antirheumatic Agents